(Q50605578)

English

Anti-albuminuric effect of the aldosterone blocker eplerenone in non-diabetic hypertensive patients with albuminuria: a double-blind, randomised, placebo-controlled trial.

scientific article published in December 2014

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

16 March 2018

http://europepmc.org/abstract/MED/25466242

Anti-albuminuric effect of the aldosterone blocker eplerenone in non-diabetic hypertensive patients with albuminuria: a double-blind, randomised, placebo-controlled trial. (English)

1 reference

Europe PubMed Central

PubMed publication ID

16 March 2018

http://europepmc.org/abstract/MED/25466242

0 references

1 reference

based on heuristic

inferred from title

author name string

Katsuyuki Ando

1

1 reference

Europe PubMed Central

PubMed publication ID

16 March 2018

http://europepmc.org/abstract/MED/25466242

Hiroshi Ohtsu

2

1 reference

Europe PubMed Central

PubMed publication ID

16 March 2018

http://europepmc.org/abstract/MED/25466242

Shunya Uchida

3

1 reference

Europe PubMed Central

PubMed publication ID

16 March 2018

http://europepmc.org/abstract/MED/25466242

Shinya Kaname

4

1 reference

Europe PubMed Central

PubMed publication ID

16 March 2018

http://europepmc.org/abstract/MED/25466242

Yoshihiro Arakawa

5

1 reference

Europe PubMed Central

PubMed publication ID

16 March 2018

http://europepmc.org/abstract/MED/25466242

Toshiro Fujita

6

1 reference

Europe PubMed Central

PubMed publication ID

16 March 2018

http://europepmc.org/abstract/MED/25466242

EVALUATE Study Group

7

1 reference

Europe PubMed Central

PubMed publication ID

16 March 2018

http://europepmc.org/abstract/MED/25466242

publication date

1 December 2014

1 reference

Europe PubMed Central

PubMed publication ID

16 March 2018

http://europepmc.org/abstract/MED/25466242

The Lancet: Diabetes & Endocrinology

1 reference

Europe PubMed Central

PubMed publication ID

16 March 2018

http://europepmc.org/abstract/MED/25466242

2

1 reference

Europe PubMed Central

PubMed publication ID

16 March 2018

http://europepmc.org/abstract/MED/25466242

12

1 reference

Europe PubMed Central

PubMed publication ID

16 March 2018

http://europepmc.org/abstract/MED/25466242

944-953

1 reference

Europe PubMed Central

PubMed publication ID

16 March 2018

http://europepmc.org/abstract/MED/25466242

Angiotensin-converting enzyme inhibition in nondiabetic progressive renal insufficiency: a controlled double-blind trial

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970194-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970194-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Renal function and requirement for dialysis in chronic nephropathy patients on long-term ramipril: REIN follow-up trial. Gruppo Italiano di Studi Epidemiologici in Nefrologia (GISEN). Ramipril Efficacy in Nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970194-9

7 January 2021

based on heuristic

inferred from DOI database lookup

The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970194-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Proteinuria, a target for renoprotection in patients with type 2 diabetic nephropathy: lessons from RENAAL.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970194-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Enhanced aldosterone signaling in the early nephropathy of rats with metabolic syndrome: possible contribution of fat-derived factors

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970194-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Podocyte injury underlies the glomerulopathy of Dahl salt-hypertensive rats and is reversed by aldosterone blocker

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970194-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of the selective aldosterone blocker eplerenone versus the calcium antagonist amlodipine in systolic hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970194-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy of eplerenone versus enalapril as monotherapy in systemic hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970194-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Beneficial effects of adding spironolactone to recommended antihypertensive treatment in diabetic nephropathy: a randomized, double-masked, cross-over study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970194-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Effectiveness of aldosterone blockade in patients with diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970194-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Selective aldosterone blockade with eplerenone reduces albuminuria in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970194-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Addition of angiotensin receptor blockade or mineralocorticoid antagonism to maximal angiotensin-converting enzyme inhibition in diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970194-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy of eplerenone added to renin-angiotensin blockade in elderly hypertensive patients: the Jichi-Eplerenone Treatment (JET) study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970194-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Rationale and design of the Eplerenone combination Versus conventional Agents to Lower blood pressure on Urinary Antialbuminuric Treatment Effect (EVALUATE) trial: a double-blinded randomized placebo-controlled trial to evaluate the antialbuminuric

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970194-9

7 January 2021

based on heuristic

inferred from DOI database lookup

CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970194-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Revised equations for estimated GFR from serum creatinine in Japan

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970194-9

7 January 2021

based on heuristic

inferred from DOI database lookup

A simple method for estimating 24 h urinary sodium and potassium excretion from second morning voiding urine specimen in adults.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970194-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Aldosterone in the development and progression of renal injury

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970194-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Normal range of human dietary sodium intake: a perspective based on 24-hour urinary sodium excretion worldwide

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970194-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Angiotensin-converting enzyme inhibitors and progression of nondiabetic renal disease. A meta-analysis of patient-level data

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970194-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Proteinuria as a surrogate outcome in CKD: report of a scientific workshop sponsored by the National Kidney Foundation and the US Food and Drug Administration

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970194-9

7 January 2021

based on heuristic

inferred from DOI database lookup

CKD treatment: time to alter the focus to albuminuria?

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970194-9

7 January 2021

based on heuristic

inferred from DOI database lookup

The incidence and implications of aldosterone breakthrough

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970194-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Sodium intake, ACE inhibition, and progression to ESRD.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970194-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of dietary sodium and hydrochlorothiazide on the antiproteinuric efficacy of losartan

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970194-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Rac1 GTPase in rodent kidneys is essential for salt-sensitive hypertension via a mineralocorticoid receptor-dependent pathway

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970194-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Modification of mineralocorticoid receptor function by Rac1 GTPase: implication in proteinuric kidney disease

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970194-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Aldosterone blunts tubuloglomerular feedback by activating macula densa mineralocorticoid receptors.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970194-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Hyperkalemia as a constraint to therapy with combination Renin-Angiotensin system blockade: the elephant in the room

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970194-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Aldosterone blockade and the mineralocorticoid receptor in the management of chronic kidney disease: current concepts and emerging treatment paradigms

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970194-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Combined angiotensin inhibition for the treatment of diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970194-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of a multifactorial intervention on mortality in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970194-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Enhanced renoprotective effects of ultrahigh doses of irbesartan in patients with type 2 diabetes and microalbuminuria

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970194-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Validation and comparison of three formulae to estimate sodium and potassium excretion from a single morning fasting urine compared to 24-h measures in 11 countries.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970194-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S2213-8587(14)70194-9

1 reference

Europe PubMed Central

PubMed publication ID

16 March 2018

http://europepmc.org/abstract/MED/25466242

release_r3uaim2g7fhezmxcbvfgtvwnce

1 reference

https://api.fatcat.wiki/v0/release/r3uaim2g7fhezmxcbvfgtvwnce

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

16 March 2018

http://europepmc.org/abstract/MED/25466242

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q50605578&oldid=2147786754"